Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.15+0.00 (+0.55%)
Close on Nov 12, 2026Market cap $11.23MP/E –Yield –
Accendra Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Accendra Health's ebitda for the twelve months ending Sep 30, 2026 was $235.12M. For fiscal 2025 it was $241.98M. Over ten years it grew -1.0% a year on average. The highest annual figure on record is $459.09M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $241.98M | – |
| FY2024 | Dec 31, 2024 | -$36.45M | -110.6% |
| FY2023 | Dec 31, 2023 | $343.60M | -7.5% |
| FY2022 | Dec 31, 2022 | $371.58M | -19.1% |
| FY2021 | Dec 31, 2021 | $459.09M | +54.3% |
| FY2020 | Dec 31, 2020 | $297.45M | +56.7% |
| FY2019 | Dec 31, 2019 | $189.83M | – |
| FY2018 | Dec 31, 2018 | -$250.42M | -268.4% |
| FY2017 | Dec 31, 2017 | $148.69M | -41.7% |
| FY2016 | Dec 31, 2016 | $254.99M | -4.3% |
| FY2015 | Dec 31, 2015 | $266.34M | +19.5% |
| FY2014 | Dec 31, 2014 | $222.94M | -10.3% |
| FY2013 | Dec 31, 2013 | $248.67M | +5.2% |
| FY2012 | Dec 31, 2012 | $236.36M | -0.5% |
| FY2011 | Dec 31, 2011 | $237.65M | +5.6% |
| FY2010 | Dec 31, 2010 | $225.08M | -0.6% |
| FY2009 | Dec 31, 2009 | $226.54M | +11.8% |
| FY2008 | Dec 31, 2008 | $202.68M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $40.25M | -55.6% |
| Q2 FY2026 | Jun 30, 2026 | $30.55M | +832.5% |
| Q1 FY2026 | Mar 31, 2026 | $78.87M | +25.8% |
| Q4 FY2025 | Dec 31, 2025 | $85.45M | – |
| Q3 FY2025 | Sep 30, 2025 | $90.57M | -2.3% |
| Q2 FY2025 | Jun 30, 2025 | $3.28M | -95.9% |
| Q1 FY2025 | Mar 31, 2025 | $62.69M | -25.2% |
| Q4 FY2024 | Dec 31, 2024 | -$291.01M | -452.8% |
| Q3 FY2024 | Sep 30, 2024 | $92.69M | -4.9% |
| Q2 FY2024 | Jun 30, 2024 | $80.80M | -2.5% |
| Q1 FY2024 | Mar 31, 2024 | $83.79M | +3.8% |
| Q4 FY2023 | Dec 31, 2023 | $82.48M | +317.6% |
| Q3 FY2023 | Sep 30, 2023 | $97.49M | -17.7% |
| Q2 FY2023 | Jun 30, 2023 | $82.90M | -44.1% |
| Q1 FY2023 | Mar 31, 2023 | $80.73M | -5.2% |
| Q4 FY2022 | Dec 31, 2022 | $19.75M | -76.6% |
| Q3 FY2022 | Sep 30, 2022 | $118.40M | +38.4% |
| Q2 FY2022 | Jun 30, 2022 | $148.25M | +24.1% |
| Q1 FY2022 | Mar 31, 2022 | $85.18M | -49.8% |
| Q4 FY2021 | Dec 31, 2021 | $84.50M | -29.3% |
| Q3 FY2021 | Sep 30, 2021 | $85.52M | -11.1% |
| Q2 FY2021 | Jun 30, 2021 | $119.48M | +153.8% |
| Q1 FY2021 | Mar 31, 2021 | $169.59M | +389.2% |
| Q4 FY2020 | Dec 31, 2020 | $119.46M | +177.7% |
| Q3 FY2020 | Sep 30, 2020 | $96.24M | +73.7% |
| Q2 FY2020 | Jun 30, 2020 | $47.09M | +2.2% |
| Q1 FY2020 | Mar 31, 2020 | $34.67M | -23.5% |
| Q4 FY2019 | Dec 31, 2019 | $43.01M | – |
| Q3 FY2019 | Sep 30, 2019 | $55.41M | +8.4% |
| Q2 FY2019 | Jun 30, 2019 | $46.08M | – |
| Q1 FY2019 | Mar 31, 2019 | $45.32M | +7.6% |
| Q4 FY2018 | Dec 31, 2018 | -$197.54M | -2155.6% |
| Q3 FY2018 | Sep 30, 2018 | $51.14M | +12.3% |
| Q2 FY2018 | Jun 30, 2018 | -$146.15M | -421.3% |
| Q1 FY2018 | Mar 31, 2018 | $42.13M | -12.4% |
| Q4 FY2017 | Dec 31, 2017 | $9.61M | -84.6% |
| Q3 FY2017 | Sep 30, 2017 | $45.52M | – |
| Q2 FY2017 | Jun 30, 2017 | $45.49M | – |
| Q1 FY2017 | Mar 31, 2017 | $48.08M | – |
| Q4 FY2016 | Dec 31, 2016 | $62.22M | – |
See a number that looks wrong?